PRESS
Molecular Lab Partners Announces 2022 Year End Results and Robust 2023 Pipeline
Organic Sales Growth Of 47% YoY Excluding COVID-19 Testing-Related Sales, FY 2022 Sales Growth Of 197% National COVID-19 Testing-Related Sales Growth Of 16% YoY Fourth Quarter New Account Expansion of 120% Over Prior Quarter OVERLAND PARK, Kan.
Molecular Lab Partners Announces Strong Third Quarter Results and Robust Q4 Pipeline
OVERLAND PARK, Kan., Oct. 19, 2021 /PRNewswire/ -- Molecular Lab Partners LLC, a national provider of turn-key Physician Office Laboratory (POL) Solutions, announced strong growth during the third quarter of 2021. The company achieved 86% revenue growth during the quarter. The growth is reflective of the strong demand for In-Office PCR Testing Solutions by physicians nationwide.
Molecular Lab Partners LLC Reports 506% Second Quarter Growth Over Prior Quarter
OVERLAND PARK, Kan., Aug. 4, 2021 /PRNewswire/ -- Molecular Lab Partners LLC, a national provider of turn-key Physician Office Laboratory (POL) Solutions, announced strong growth during the second quarter of 2021. The company achieved 506% revenue growth during the quarter. The growth is reflective of the strong demand for In-Office PCR Testing Solutions by physicians nationwide.